CMA1 and neoplasm: Differences between the above studies and our results may be explained on the basis of different methods to identify MCs (toluidine blue, anti-tryptase antibody, and anti-chymase antibody), methods to assess MCs count (hot spots, random fields, and magnification), type of studied tissue (biopsy or surgically resected tumour), and stage of disease.